 Participants received intramuscular injections of palivizumab according to physicians prescription and the local label. The local label recommended 1 month injection intervals between 5 sequential injections at a dose of 15 mgkg. Participants could have received from 3 to 5 monthly injections of palivizumab during the 2014 - 2015 RSV season and the duration of this study. 